Table 1.

Demographic characteristics, duration of diabetes, and the duration of the phacoemulsification time in patients with diabetic retinopathy receiving diclofenac and placebo

	No. (%) of patients
Characteristics	diclofenac group (n = 27)	placebo group (n = 28)	P*
Age (median, range; years)	73 (59–81)	70 (47–82)
Sex
women	13 (48.1)	14 (50.0)
men	14 (51.9)	14 (50.0)
Duration of diabetes (median, range; years)	18.9 (5.0-35.0)	16.7 (10.0-28.0)	0.420
Phacoemulsification time (median, range; cde†)	16.6 (5.8-50.1)	15.3 (2.2-50.1)	0.630

*Student’s t-test.

^†cde - cumulative dissipated energy.